Skip to Content
Rebecca S Sippel, MD

Contact Dr. Sippel

E-mail:
sippel@surgery.wisc.edu

Phone:
(608) 263-1387

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CNTR-H4
MADISON, WI 53792-3284

Rebecca S Sippel, MD

Associate Professor and Chief, Division of Endocrine Surgery
Divisions of General Surgery

Education

  • MD, Washington University School of Medicine, St. Louis, MO, 1999
  • Residency, University of Wisconsin Hospitals and Clinics, Madison, WI, 1999-2006
  • Postdoctoral Research Fellowship, University of Wisconsin Comprehensive Cancer Center, Endocrine Surgery Research Lab, 2001-2003
  • Fellowship in Endocrine Surgery, University of California- San Francisco, CA, 2006-2007

Dr. Sippel is the Endocrine Surgery Fellowship Director.

Clinical Specialties

Dr. Sippel is certified by the American Board of Surgery. She specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. She utilizes several minimally invasive techniques to treat endocrine disorders (minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer). She has a special interest in treating patients with Graves’ disease, hyperparathyroidism and recurrent thyroid cancer.

Dr. Sippel provides a wide range of services including Adrenal Surgery, Central Neck Dissection, Endocrine Surgery, Fine Needle Aspiration (FNA), Laparoscopic Adrenalectomy, Minimally Invasive Parathyroidectomy, Minimally Invasive Radioguided Parathyroidectomy (MIRP), Modified Radical Neck Dissection, Neck Ultrasound, Open Adrenalectomy, Parathyroid Surgery, Resection Of Substernal Goiter, Subtotal Parathyroidectomy, Thyroidectomy, Thyroid Lobectomy, Thyroid Surgery, and Total Thyroidectomy.

Research Interests

Dr. Sippel conducts translational research at the University of Wisconsin Comprehensive Cancer Center. Her research program investigates the development and treatment of endocrine tumors with a special interest in thyroid cancer. She also conducts clinical research working on improving the care and outcomes of patients with endocrine tumors.

Funding/Grants

Active Clinical Trials

Recent Publications
  • Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism.
    Lowell AJ, Bushman NM, Wang X, Ma Y, Pitt SC, Sippel RS, Schneider DF, Randle RW
    J. Surg. Res. 2017 Sep; 217():252-257.
    [PubMed ID: 28711370, PMC ID: 5603402]
    More Information
  • Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes.
    Price AK, Randle RW, Schneider DF, Sippel RS, Pitt SC
    J. Surg. Res. 2017 Oct; 218():237-245.
    [PubMed ID: 28985856]
    More Information
  • Papillary Thyroid Cancer: The Good and Bad of the "Good Cancer".
    Randle RW, Bushman NM, Orne J, Balentine CJ, Wendt E, Saucke M, Pitt SC, Macdonald CL, Connor NP, Sippel RS
    Thyroid 2017 Jul; 27(7):902-907.
    [PubMed ID: 28510505, PMC ID: 5561445]
    More Information
  • Encapsulated follicular variant of papillary thyroid cancer: are these tumors really benign?
    Aburjania Z, Jang S, Montemayor-Garcia C, Lloyd RV, Schneider DF, Sippel RS, Chen H, Elfenbein DM
    J. Surg. Res. 2017 Aug; 216():138-142.
    [PubMed ID: 28807198, PMC ID: 5608032]
    More Information
  • Optimizing Outpatient Pain Management After Thyroid and Parathyroid Surgery: A Two-Institution Experience.
    Lou I, Chennell TB, Schaefer SC, Chen H, Sippel RS, Balentine C, Schneider DF, Moalem J
    Ann. Surg. Oncol. 2017 Jul; 24(7):1951-1957.
    [PubMed ID: 28160140, PMC ID: 5451307]
    More Information

webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System